Get started
Merck & Co. (NYSE: $MRK) Sets Up Q125 Earnings Call for April 24Merck & Co. (NYSE: NYSE:MRK ) will hold its Q1 2025 earnings call on April 24 at 9:00 a.m. ET. Company executives will present financial results and performance updates during the call. As of April 4th, 2025, MRK closed at $81.47, down $4.92 (5.70%). The stock has declined steadily since peaking at $134 in June 2024. In Q4 2024, Merck posted global sales of $15.6 billion, a 7% increase from the previous year. Sales growth stood at 9% when excluding foreign exchange effects. Full-year 2024 revenue reached $64.2 billion, a 7% increase over 2023. Human health sales grew 8%, driven mainly by oncology treatments. KEYTRUDA remained the company’s top product with sales of $7.8 billion in Q4, rising 21%. WINREVAIR generated $200 million in sales, while new vaccine CAPVAXIVE added $50 million. The Animal Health division showed strong momentum, growing 13% year-over-year. Merck’s global reach extended to nearly 500 million people in 2024. However, GARDASIL vaccine sales dropped 18% in Q4 due to lower demand in China. This led Merck to pause GARDASIL shipments to the region temporarily. Operating expenses for the quarter totaled $7.4 billion. The company reported a gross margin of 80.8%, up by 3.6 percentage points. Earnings per share came in at $1.72. For 2025, Merck expects revenue between $64.1 billion and $65.6 billion. EPS guidance is set at $8.88 to $9.03, excluding foreign exchange impact. The Medicare Part D redesign could reduce revenue by about $400 million in 2025. This would affect WINREVAIR and other small molecule oncology drugs. Technical Analysis MRK stock is currently testing a major support level at $81.A confirmed breakdown at this critical level could push the stock lower. Price momentum and volume suggest a likely continuation of the bearish trend unless support holds. With the bearish pressure in place, the next support level lies at $70. The weekly chart shows consistent lower highs and lower lows since June 2024. MRK has fallen nearly 65% from its peak of $134. If the $81 current support holds, a short-term rebound is possible, with an immediate resistance target around $95. Reclaiming this level may signal early signs of a trend reversal. If a strong break at the $81 level is witnessed, the next target remains the $70 support. The current trend favors sellers. One thing to watch closely is the April 24th, 2025, earnings call as performance updates may provide clarity on near-term price direction.
NYSE:MRKShort
by DEXWireNews
Bear Flags: $NVDA first, then $AVGO In this AI Mega cycle there were 2 clear visible winners. NASDAQ:NVDA and $AVGO. Broadcom ( NASDAQ:AVGO ) has had a late bull run in the AI super cycle which started in 2022 and was ongoing until Dec 2024. During this tariff-based bear run NASDAQ:NVDA is almost down 40%. The same is true for Broadcom. NASDAQ:AVGO is also down 40% from the ATH. But we must investigate the confluence of some more technical indicators on top of the simple % drawdown we see in stocks. The 2 most helpful indicators are the RSI and Fib retracement levels, which can give us some more price levels which we might be looking forward to in the upcoming weeks. The RSI is at 36 on the weekly chart for both the stocks NASDAQ:AVGO and $NVDA. But let’s focus on NASDAQ:AVGO in this blog. Today we are combining the Gan and Fib retracements levels on the weekly chart of NASDAQ:AVGO and we see the clear price levels. We are already at 0.618 Fib retracement which is the price level 145. We closed @ 146 $ on Friday. If we break tis support level, then the next level we are looking at is 121 $ which will be 0.5 Fib retracement levels. If that level is broken, then we are looking at a 100 $ Stock price on $ AVGO 0.382 Fib retracement level. Verdict: Buy 33% now, buy 33% between 120 $ - 130 $ , buy the rest 33% between 95 $ - 100 $
NASDAQ:AVGO
by RabishankarBiswal
Reddit DeathcrossThe market is selling of and we are witnessing a brutal drop on Reddit, arguably the best recent IPO. I fully expect the downtrend to continue. I did warn traders and investors that we will have a large drop in tech, particularly in names like Monday, Tesla. Smart money was positioning in safer names like Nestle, please look at my trade idea for that. I do like Reddit but its valuation was inflated. If $100 doesn’t hold I expect the gap to be filled around $80-85. That could be a place for long term investors to initiate a position. Not financial advice, do what’s best for you.
NYSE:RDDT
by NoFOMO_
5
ROKU long positionROKU is a video streaming platform which is poised for strong growth, driven by its expanding user base, innovative offerings and strategic partnerships. Analysts label it as a comepelling long-term investment opportunity. However, ROKU isn’t trading at a reasonable entry price, in terms of technicals, so I would suggest the following: - Wait for the price to drop to the previous higher low of $66.3 to enter this trade - Put a stop-loss at $63.1 - Target a share price of $96.3
NASDAQ:ROKULong
by vf_investment